Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 52, Issue 10, 2003, Pages 1274-1278

  Yatagai, Toshimitsu ^a,b,c   Nagasaka, Shoichiro ^a,b,c   Taniguchi, Ataru ^a,b,c   Fukushima, Mitsuo ^a,b,c   Nakamura, Tomoatsu ^a,b,c   Kuroe, Akira ^a,b,c   Nakai, Yoshikatsu ^a,b,c   Ishibashi, Shun ^a,b,c  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b KANSAI DENRYOKU HOSPITAL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C PEPTIDE; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL; LEPTIN; PROTEIN; SIGNAL PEPTIDE;

ABDOMEN; ADULT; AGE; AGED; ARTICLE; BODY FAT; BODY MASS; BONE MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETIC DIET; DIABETIC OBESITY; DIET RESTRICTION; DISEASE DURATION; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; SUBCUTANEOUS FAT; UMBILICUS; VISCERA; ADIPOSE TISSUE; ASIAN; BLOOD; BODY COMPOSITION; ETHNOLOGY; HOMEOSTASIS; JAPAN; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY;

ADIPONECTIN; ADIPOSE TISSUE; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY COMPOSITION; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JAPAN; LEPTIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTEINS; RADIOIMMUNOASSAY; VISCERA;

EID: 0242304261     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00195-1     Document Type: Article

References (32)

1. Arita Y, Kihara S, Ouchi N, et al: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83, 1999
2. Hotta K, Funahashi T, Arita Y, et al: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595-1599, 2000
3. Weyer C, Funahashi T, Tanaka S, et al: Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935, 2001
4. Stefan N, Vozarova B, Funahashi T, et al: Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 50:1884-1888, 2002
5. Lindsay RS, Funahashi T, Hanson RL, et al: Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360:57-58, 2002
6. Taniguchi A, Nakai Y, Sakai M, et al: Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients. Metabolism 51:544-548, 2002
7. Nagasaka S, Ishikawa S, Nakamura T, et al: Association of endogenous insulin secretion and mode of therapy with body fat and serum leptin levels in diabetic subjects. Metabolism 47:1391-1396, 1998
8. World Health Organization: Diabetes Mellitus: Report of a WHO study group. WHO Tech Rep Ser 727, 1985
9. Taniguchi A, Fukushima M, Sakai M, et al: Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care 23:1766-1769, 2000
10. Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
11. Emoto M, Nishizawa Y, Maekawa K, et al: Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22:818-822, 1999
12. Bonora E, Targher G, Alberiche M, et al: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57-63, 2000
13. 40K, and tritium. Am J Physiol 250:E736-E745, 1986
14. 40K. Int J Obes 12:249-266, 1988
15. Statnick MA, Beavers LS, Conner LJ, et al: Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res 1:81-88, 2000.
16. Yamauchi T, Kamon J, Waki H, et al: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946, 2001
17. Berg AH, Combs TP, Du X, et al: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953, 2001
18. Maeda N, Shimomura I, Kishida K, et al: Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731-737, 2002
19. Fruebis J, Tsao T-S, Javorschi S, et al: Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98:2005-2010, 2001
20. Abate N, Garg A, Peshock RM, et al: Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 45:1684-1693, 1996
21. Banerji MA, Chaiken RL, Gordon D, et al: Does intra-abdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive? Diabetes 44:141-146, 1995
22. Gautier J-F, Mourier A, De Kerviler E, et al: Evaluation of abdominal fat distribution in noninsulin-dependent diabetes mellitus: Relationship to insulin resistance. J Clin Endocrinol Metab 83:1306-1311, 1998
23. Banerji MA, Faridi N, Atluri R, et al: Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 84:137-144, 1999
24. Kelly DE, Williams KV, Price JC, et al: Plasma fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus. J Clin Endocrinol Metab 86:5412-5419, 2001
25. Matsubara M, Maruoka S, Katayose S: Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87:2764-2769, 2002
26. Taniguchi A, Fukushima M, Sakai M, et al: The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients. Metabolism 49:1001-1005, 2000
27. Nagaretani H, Nakamura T, Funahashi T, et al: Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance. Diabetes Care 24:2127-2133, 2001
28. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 45:3-10, 1996
29. Ouchi N, Kihara S, Arita Y, et al: Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein, adiponectin. Circulation 100:2473-2476, 1999
30. Ouchi N, Kihara S, Arita Y, et al: Adiponectin, adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through cAMP-dependent pathway. Circulation 102:1296-1301, 2000
31. Ouchi N, Kihara S, Arita Y, et al: Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103:1057-1063, 2001
32. Kondo H, Shimomura I, Matsukawa Y, et al: Association of adiponectin mutation with type 2 diabetes. A candidate gene for the insulin resistance syndrome. Diabetes 51:2325-2328, 2002